You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

P23H mutation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

People Who Have Genetic Changes and Features of Autism: Simons

Recruiting
  • 16P11.2 Deletion Syndrome
  • +184 more
    • New York, New York
    • +1 more
    Jan 6, 2023

    Retinitis Pigmentosa Trial in Ann Arbor (Hydroxychloroquine lower dose, Hydroxychloroquine higher dose)

    Recruiting
    • Retinitis Pigmentosa
    • Hydroxychloroquine lower dose
    • Hydroxychloroquine higher dose
    • Ann Arbor, Michigan
      University of Michigan
    Feb 14, 2022

    Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

    Terminated
    Has Results
    • Acute Biphenotypic Leukemia
    • +29 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 4, 2023

    Retinitis Pigmentosa Trial in Durham (ADX-2191)

    Recruiting
    • Retinitis Pigmentosa
    • Durham, North Carolina
      Duke Eye Center
    Sep 26, 2022

    Brodalumab in Plaque Psoriasis to Understand Impact on Quality

    Recruiting
    • Psoriasis
    • Brodalumab
    • Matched cohort
    • Calgary, Alberta, Canada
    • +33 more
    Oct 8, 2022

    Herpes Zoster, Herpes Zoster Vaccine Trial in Canada, Estonia, United States (Herpes Zoster vaccine GSK 1437173A, Licensed

    Completed
    Has Results
    • Herpes Zoster
    • Herpes Zoster Vaccine
    • Herpes Zoster vaccine GSK 1437173A
    • Licensed pneumococcal polysaccharide conjugate vaccine (23-valent, adsorbed), Pneumovax 23™
    • Golden, Colorado
    • +8 more
    Apr 19, 2021

    NSCLC Trial in Worldwide (Poziotinib)

    Active, not recruiting
    • NSCLC
    • Phoenix, Arizona
    • +62 more
    Jan 27, 2023

    InheriteD brEast caNcer iTalian regIsTrY A

    Recruiting
    • Breast Cancer
      • Aviano, Pordenone, Italy
      • +11 more
      Apr 26, 2023

      Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis Trial in Worldwide (sepofarsen, Sham)

      Active, not recruiting
      • Leber Congenital Amaurosis 10
      • +9 more
      • Iowa City, Iowa
      • +13 more
      Mar 2, 2022

      Chronic Lymphocytic Leukemia Trial in Worldwide (Venetoclax)

      Completed
      Has Results
      • Chronic Lymphocytic Leukemia
      • Louisville, Kentucky
      • +66 more
      Nov 9, 2022

      Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,

      Active, not recruiting
      Has Results
      • Acute Myeloid Leukemia With FLT3/ITD Mutation
      • +5 more
      • Biopsy
      • +7 more
      • Lewes, Delaware
      • +42 more
      Mar 15, 2022

      Non Small Cell Lung Cancer Trial in Worldwide (AZD9291)

      Active, not recruiting
      Has Results
      • Non Small Cell Lung Cancer
      • La Jolla, California
      • +43 more
      Nov 25, 2022

      EGF-R Positive NSCLC, Non Small Cell Lung Cancer, EGFR Exon 19 Deletion Trial in Bogotá (Stereotactic Body Radiation Therapy

      Not yet recruiting
      • EGF-R Positive Non-Small Cell Lung Cancer
      • +4 more
      • Stereotactic Body Radiation Therapy SBRT
      • Bogotá, Colombia
        CTIC - Centro de Tratamiento e Investigación Sobre Cáncer Luis C
      Aug 16, 2023

      Histiocytosis Trial in Warsaw (Vemurafenib)

      Recruiting
      • Histiocytosis
      • Warsaw, Mazovian, Poland
        Mother and Child Institute
      Aug 2, 2022

      NSCLC Trial in Singapore (Afatinib 40 MG)

      Not yet recruiting
      • NSCLC
      • Afatinib 40 MG
      • Singapore, Singapore
        National University Hospital
      Sep 25, 2023

      Melanoma Trial in Ottawa, Toronto, Montreal (Vemurafenib, Cobimetinib)

      Active, not recruiting
      • Melanoma
      • Ottawa, Ontario, Canada
      • +2 more
      Oct 25, 2022

      Advanced HER2+Breast Cancer Trial in Worldwide (Alpelisib, Alpelisib matching Placebo, Trastuzumab)

      Active, not recruiting
      • Advanced HER2+Breast Cancer
      • Fayetteville, Arkansas
      • +98 more
      Dec 16, 2022

      Ischemic Stroke, Transient Ischemic Attack Trial in Singapore (Genetic testing)

      Not yet recruiting
      • Ischemic Stroke
      • Transient Ischemic Attack
      • Genetic testing
      • Singapore, Singapore
        Singapore General Hospital
      Mar 9, 2023

      Mitochondrial Myopathies Trial in Maastricht (Intra-arterial delivery of autologous MABs)

      Recruiting
      • Mitochondrial Myopathies
      • Intra-arterial delivery of autologous MABs
      • Maastricht, Netherlands
        Maastricht University Medical Center
      Jul 24, 2023

      Amyotrophic Lateral Sclerosis Trial in Worldwide (BIIB067, Placebo)

      Completed
      • Amyotrophic Lateral Sclerosis
      • Phoenix, Arizona
      • +39 more
      Jul 15, 2022

      Alzheimers Disease, Dementia, Alzheimers Disease, Familial Trial in Worldwide (Gantenerumab, Matching Placebo (Gantenerumab))

      Suspended
      • Alzheimers Disease
      • +2 more
      • Birmingham, Alabama
      • +34 more
      Jan 10, 2023

      Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

      Recruiting
      • Rare Disorders
      • +309 more
        • Sioux Falls, South Dakota
        • +1 more
        Jun 20, 2022

        KCNJ11-related Intermediate Developmental Delay, Epilepsy and

        Recruiting
        • Neurodevelopmental Disorders
        • +5 more
        • Chicago, Illinois
        • +3 more
        Feb 20, 2023

        Slow-Flow Vascular Malformation, Fast-Flow Vascular Malformation, Vascular Malformations Trial in Parkville (Alpelisib,

        Not yet recruiting
        • Slow-Flow Vascular Malformation
        • +17 more
        • Parkville, Victoria, Australia
          The Royal Children's Hospital
        Aug 7, 2023

        Alzheimers Disease, Dementia, Alzheimers Disease, Familial Trial in Worldwide (Gantenerumab, Solanezumab, Matching Placebo

        Completed
        Has Results
        • Alzheimers Disease
        • +2 more
        • Birmingham, Alabama
        • +24 more
        Aug 25, 2022